Clinical Symptoms of Multiple Myeloma and their Validity in the Detection of symptomatic Progression and Relapse
- Conditions
- C90.0Multiple myeloma
- Registration Number
- DRKS00024789
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1. Adult patients with newly diagnosed MM.
2. Adult patients with Multiple Myeloma treated at the University Hospital Freiburg irrespective of previous treatment (especially kind of drugs); first or second line treatment.
Exclusion Criteria
Underaged patients, patients without Multiple Myeloma, patients with known other malignancy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differences of clinical symptoms in patients with stable disease and patients with symptomatic progression/relapse, respectively.<br><br>Correlation of biochemical and/or radiographic progression and symptoms in MM-patients – Are clinical symptoms suitable for early detection of symptomatic progression/relapse?<br><br>Assessment via questionnaire in our outpatient clinic during routine visits.
- Secondary Outcome Measures
Name Time Method Clinical symptoms of MM at first MM-diagnosis Analysis of previous results in a larger cohort.<br>Differences in clinical symptoms at first diagnosis and at symptomatic progression/relapse (questionnaire).<br>Definition of clinical warning signs of MM and symptomatic progression/relapse.<br>